JUL 22, 2019 9:45 AM PDT

Don't Combine Breast and Gyno Surgery, Study Advises

WRITTEN BY: Julia Travers

Surgeries can be stressful and difficult for patients, and it’s understandable that some would want to reduce the number of days they need to devote to surgical procedures. This desire has led some women to choose to combine breast and gynecologic procedures, such as cancer-preventive breast surgeries, hysterectomy and/or ovarian removal, into a single hospital visit. But, a new study out of the University of Colorado (CU) Cancer Center recently published in Breast Journal advises against this practice. This recommendation is based on an analysis of data from the National Surgery Quality Improvement Program (NSQIP) database.

The researchers involved found several negative trends associated with doubling up on these surgeries, including higher complication, readmission, and reoperation rates, a much longer length of stay at the hospital (compared to patients who had a single site surgery). These findings were drawn from the records of 77,030 women who had breast surgery between 2011 and 2015, 124 of whom also had a gynecologic surgery at the same time. Usually, younger women made this choice, but this group still showed the higher rate of surgery complications. 

“In patients at high risk of developing breast cancer and ovarian cancer, we recommend doing the prophylactic bilateral mastectomy along with breast reconstruction, but then trying to keep gynecologic surgery separate. It's safer and easier to do them separately," Dr. Sarah Tevis, CU Cancer Center investigator and breast surgeon at UC Health University of Colorado Hospital, told EurekAlert

Treatment delays tied to scheduling difficulties are also sometimes associated with combining surgical procedures. And, complications can delay the start of chemo for some patients, which has further ramifications. 

Tevis points out that, for some patients, a medical condition may make combining surgeries and only undergoing anesthesia once preferable. But she describes these cases as “rare.” Further research on these topics will attempt to identify which women will have better or worse reactions to the various surgical scheduling approaches. 

Article source: EurekAlert

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JAN 11, 2020
Cancer
JAN 11, 2020
Should we be concerned about talc powder and ovarian cancer?
After the outcry against baby powder and concerns regarding its link to ovarian cancer, still, no investigations have clearly linked the product to the dis...
JAN 20, 2020
Genetics & Genomics
JAN 20, 2020
Epigenetic Changes Make Breast Cancer Cells Drug Resistant
Researchers have found that changes in the structure of the genome in breast cancer cells can make them resistant to drug therapies....
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrating host-rejection responses agains...
MAR 03, 2020
Cancer
MAR 03, 2020
New technique maps tissue development and tumors
Research published recently in the Proceedings of the National Academy of Sciences details the development of a new technique that is capable of mappi...
MAR 18, 2020
Cancer
MAR 18, 2020
Statins could reduce heart damage from breast cancer treatment
Cancer treatments have a lot of side effects. For breast cancer chemotherapies that use drugs like anthracycline and trastuzumab, one of those side ef...
MAR 24, 2020
Clinical & Molecular DX
MAR 24, 2020
Ultra sensitive cancer diagnostic detects DNA "fingerprints" in liquid biopsies
  Researchers from the Broad and Dana-Farber Cancer Institutes have developed a diagnostic technology that can monitor for the presence of recurring c...
Loading Comments...